Why the study?
Although some carotenoids suppress NASH progression in mice, it remains unclear whether beta-carotene is effective against NASH.
Does beta-carotene prevent the progression of NASH in a diet-induced mouse model?
Does beta-carotene prevent the progression of NASH in a diet-induced mouse model?
High-dose beta-carotene supplementation suppresses hepatic lipid accumulation and lobular inflammation in a mouse model of diet-induced NASH.
High-dose β-carotene effects in mice warrant no clinical change; leaves open human efficacy trials for NASH.
Non-alcoholic steatohepatitis (NASH) is a globally recognized liver disease. Anti-oxidative vitamins, such as vitamin C (VC) and vitamin E (VE), are used to treat NASH in humans. In addition, some carotenoids (e.g., astaxanthin, β-cryptoxanthin, fucoxanthin, lycopene, and zeaxanthin) could suppress the progression of NASH in a mouse model. However, it is unclear whether β-carotene is effective against NASH. Therefore, we examined the effects of β-carotene on diet-induced NASH in mice. C57BL/6J male mice (10 weeks of age) were fed a control diet or NASH diet containing various amounts of β-carotene (0.0005%-0.5% [w/w]). A 12-week feeding NASH diet induced NASH in a mouse model. This model presented increased liver weight, plasma levels of hepatic marker enzymes (aspartate transaminase; AST, alanine transaminase; ALT), hepatic triglycerides (TG) content, and NAFLD activity score. The physiological dose (0.0005%-0.005%) of β-carotene failed to suppress the progression of NASH. However, high-dose (0.5%) of β-carotene suppressed hepatic lipid accumulation and NASH progression, especially lobular inflammation, in the NAFLD activity score. In conclusion, a high-dose of β-carotene intake prevented hepatic lipid accumulation and the progression of NASH in a mouse model. In contrast, the physiological dose of β-carotene did not show any beneficial effects on NASH. However, β-carotene's presence in food is valuable and could be expanded to reflect real-world implications. Further studies, especially observational studies, are needed to clarify whether β-carotene can prevent the progression of NASH in humans. Practical Application: The physiological dose of β-carotene did not show any beneficial effects on NASH. However, a high-dose of β-carotene suppressed the progression of NASH, especially steatosis and lobular inflammation, in a mouse model. Further studies are needed to clarify whether β-carotene can prevent the progression of NASH in humans. β-Carotene is known to have various biological functions in addition to its role as provitamin A. So, active consumption of β-carotene via regular foods, but not dietary supplements, is recommended, even if the effect on NASH in humans is unclear.
No takes yet. Share an insight, caveat, or question.
Suzuki et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: